Diagnostic tools have great impact on timely detecting and inhibiting the progression of diseases. The nanomedicine activities in this area comprise of introducing new nano-based tools and analysis procedures, as well as developing the current methods.

Delivery and co-delivery of genes and drugs via nano-carriers is a modern and effective approach in treatment of many diseases, especially various types of cancers. Our team has great expertise in designing and synthesis of nano-carriers for particular purposes, smart targeting, encapsulating them, and designing unique strategies for their release.

Our team in nanomedicine group perform all required studies in preclinical trials in a project, such as experimental tests, biological assays, in vitro and in vivo studies.

Another area of nanomedicine activities is producing nano-based productions mostly applied in the diagnosis and treatment of disease. This part of the company is also involved in producing conventional drugs in partnership with other pharmaceutical companies. Additionally, our nanomedicine team can contribute to innovative projects, to develop, industrialize, and ultimately deliver them to the market.